Key result
Genotype 1-based modified live virus vaccines likely drove classical swine fever virus evolution, with genotype 2 evolving at a higher rate and under lower immune pressures than genotype 1.
Disproportionate usage of CSF MLVs in endemic areas drives evolutionary changes in CSFV, highlighting the risk of vaccine-escaping mutants.
May heighten risk of CSFV vaccine escape; leaves open need for genotype-specific MLV reformulation.
Modified live vaccines (MLVs) based on genotype 1 strains, particularly C-strain, have been used to prevent and control classical swine fever virus (CSFV) worldwide. Nevertheless, a shift in the predominant CSFV strains circulating in the field from genotype 1 or 3 to genotype 2 is seen. Genotype 2 is genetically distant from the vaccine strains and was recently reported during outbreaks after vaccine failure; this has raised concerns that vaccination has influenced viral evolution. In Korea in 2016, there was an unexpected CSF outbreak in a MLV-vaccinated commercial pig herd. The causative CSFV strain was genetically distinct from previously isolated Korean strains but similar to recent Chinese strains exhibiting enhanced capacity to escape neutralization; this suggests the need for global cooperative research on the evolution of CSFV. We analysed global E2 sequences, using bioinformatics tools, revealing the evolutionary pathways of CSFV. Classical swine fever virus genotypes 1 and 2 experienced different degrees and patterns of evolutionary growth. Whereas genotype 1 stayed relatively conserved over time, the genetic diversity of genotype 2 has progressively expanded, with few fluctuations. It was determined that genotype 2 evolved under lower immune pressures and at a higher evolutionary rate than genotype 1. Further, several selected codons, under diversifying selection in genotype 1 but under purifying selection in genotype 2, correspond to antigenic determinants, which could lead to evasion of vaccine-induced immunity. Our findings provide evidence that evolutionary changes in CSFV are the result of the disproportionate usage of the CSF MLVs in endemic areas; this underscores the need to develop mitigation strategies to minimize the substantial risk associated with the emergence of vaccine-escaping mutants.
No takes yet. Share an insight, caveat, or question.
Yoo et al. (2018) studied Classical swine fever virus (CSFV). Genotype 1-based modified live virus vaccine was evaluated on Evolutionary pathways and genetic diversity of CSFV genotypes 1 and 2. Genotype 1-based modified live virus vaccines likely drove classical swine fever virus evolution, with genotype 2 evolving at a higher rate and under lower immune pressures than genotype 1.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: